TGFB1 and neoplasm: Recent studies have demonstrated that reversing EMT, by blocking TGF-β signaling with TGF-β type I receptor kinase inhibitors, enhances the anti-tumor effects of paclitaxel on TNBC and attenuates metastasis after treatment [17, 18].